Contact this trialFirst, we need to learn more about you.
Sotevtamab and FOLFOX for Colorectal Cancer
Recruiting1 awardPhase 2
Montréal, Quebec
This trial will include 17 patients with colorectal cancer that has spread to the liver. The patients will be given a drug called Sotevtamab once a week for 6 cycles, along
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.